Rohit L Loomba (Rohit Loomba, Naim Alkhouri)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Magnetic Resonance Imaging

Top Venues

Hepatology communications

Hepatology (Baltimore, Md.)

Liver international : official journal of the International Association for the Study of the Liver

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine (2024)
Rohit L Loomba, Leo Tseng, Kemal Balic, Hank Mansbach, Maya Margalit
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Leo Tseng, Kemal Balic, Hank Mansbach, Maya Margalit
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine 391 (4) (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine 391 (4) (2024)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Stephen Caldwell, Arun J Sanyal, Kris V Kowdley, Deepak L Bhatt, Rohit L Loomba, Juan Pablo Frias, Pierre Bedossa, Stephen A Harrison, Donald Lazas, Robert Barish, Mildred D Gottwald, Shibao Feng, Germaine D Agollah, Cynthia L Hartsfield, Hank Mansbach, Maya Margalit, Manal F Abdelmalek
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH. The New England journal of medicine (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Julia Y Payne, Rohit L Loomba, Phuc Le, Michael B Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018. Hepatology communications 7 (1) (2023)
Julia Y Payne, Rohit L Loomba, Phuc Le, Michael B Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018. Hepatology communications 7 (1) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Julia Y Payne, Rohit L Loomba, Phuc Le, Michael B Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018. Hepatology communications 7 (1) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Julia Y Payne, Rohit L Loomba, Phuc Le, Michael B Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018. Hepatology communications 7 (1) (2023)
Julia Y Payne, Rohit L Loomba, Phuc Le, Michael B Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018. Hepatology communications 7 (1) (2023)
Rohit L Loomba, Donald Lazas, Rohit Loomba, Juan P Frias, Shibao Feng, Leo Tseng, Kemal Balic, Germaine D Agollah, Tinna Kwan, Janani S Iyer, Linda Morrow, Hank Mansbach, Maya Margalit, Stephen A Harrison
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Rohit L Loomba, Ashraf Almomani, Phuc Le, Julia Y Payne, Imad Asaad, Celine Sakkal, Miriam Vos, Mazen Noureddin, Prabhat Kumar
The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database. BMC gastroenterology 22 (1) (2022)
Nawras Habash, Yamen Ezaizi, Ibrahim Kak, Praveen Kumar Conjeevaram Selvakumar, Rocio Lopez, Rohit L Loomba, Mohammad Nasser Kabbany
Accuracy of noninvasive fibrosis scores in predicting advanced fibrosis in pediatric patients after liver transplantation. Pediatric transplantation 26 (5) (2022)
Rohit L Loomba
MRI-Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) 73 (3) (2021)
Jonathan G Stine, Ian R Schreibman, Alison J Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R Kimball, Nathaniel G Geyer, Vernon M Chinchilli, Rohit L Loomba, Kathryn Schmitz, Christopher Sciamanna
NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology (Baltimore, Md.) (2021)
Rohit Loomba, Mazen Noureddin, Kris V Kowdley, Anita Kohli, Aasim Sheikh, Guy Neff, Bal Raj Bhandari, Nadege Gunn, Stephen H Caldwell, Zachary Goodman, Ilan Wapinski, Murray Resnick, Andrew H Beck, Dora Ding, Catherine Jia, Jen-Chieh Chuang, Ryan S Huss, Chuhan Chung, G Mani Subramanian, Robert P Myers, Keyur Patel, Brian B Borg, Reem Ghalib, Heidi Kabler, John Poulos, Ziad Younes, Magdy Elkhashab, Tarek Hassanein, Rajalakshmi Iyer, Peter Ruane, Mitchell L Shiffman, Simone Strasser, Vincent Wai-Sun Wong, Rohit L Loomba, null null
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. Hepatology (Baltimore, Md.) 73 (2) (2021)
Nobuharu Tamaki, Kento Imajo, Suzanne Sharpton, Jinho Jung, Nobuyoshi Kawamura, Masato Yoneda, Mark A Valasek, Cynthia Behling, Claude B Sirlin, Nobuyoshi Kawamura, Rohit L Loomba
MRE plus FIB-4 (MEFIB) versus FAST in detection of candidates for pharmacological treatment of NASH-related fibrosis. Hepatology (Baltimore, Md.) (2021)
Aleah L Brubaker, Rohit L Loomba
Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allograft and Nonalcoholic Steatohepatitis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
Nilay Danis, Sharon R Weeks, Ahyoung Kim, Azarakhsh Baghdadi, Maryam Ghadimi, Ihab R Kamel, Behnam Saberi, Tinsay Woreta, Jacqueline Garonzik-Wang, Benjamin Philosophe, Ahmet Gurakar, Rohit L Loomba
Non-invasive Risk Stratification for NAFLD Among Living Liver Donor Candidates: A Proposed Algorithm. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
Nabil Noureddin, Jörn M Schattenberg, Rohit L Loomba, Mazen Noureddin
Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass? Hepatology communications 4 (2) (2020)
Rohit L Loomba, Anita Kohli, Rohit Loomba, Stephen A Harrison
Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic. Hepatology (Baltimore, Md.) 72 (5) (2020)
Elizabeth M Brunt, David E Kleiner, Danielle H Carpenter, Mary Rinella, Stephen A Harrison, Rohit L Loomba, Zobair M Younossi, Brent A Neuschwander-Tetri, Arun J Sanyal, null null
Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice. Hepatology (Baltimore, Md.) (2020)
Quentin M Anstee, Eric J Lawitz, Rohit L Loomba, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Kathryn Kersey, Georgia Li, Ling Han, Catherine Jia, Lulu Wang, Guang Chen, G Mani Subramanian, Robert P Myers, C Stephen Djedjos, Anita Kohli, Natalie Bzowej, Ziad Younes, Shiv Kumar Sarin, Mitchell L Shiffman, Stephen A Harrison, Nezam H Afdhal, Zachary Goodman, Zobair M Younossi
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. Hepatology (Baltimore, Md.) 70 (5) (2019)
Rohit L Loomba, Eric Lawitz, Mazen Noureddin
Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment. Hepatology communications 3 (5) (2019)
Rohit L Loomba, Rohit Kohli, Ariel E Feldstein
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints. Hepatology communications 3 (12) (2019)
Rohit L Loomba, Casey Johnson, Leon Adams, Sachiko Kitajima, Chikayuki Tsuruno, Tracey L Colpitts, Kazuki Hatcho, Eric Lawitz, Rocio Lopez, Ariel E Feldstein
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis. PloS one 13 (8) (2018)